LeeRetinaLab investigates the pathobiology of age-related macular degeneration and diabetic retinopathy, with a focus on developing extracellular vesicle (EV)-based therapeutics. Our team has expertise in small EV (sEV) isolation, characterization, and bioengineering, and we regularly work with relevant animal models. To optimize sEV-based intraocular therapies, we apply both conventional and advanced technologies, including single-particle analysis, nano-flow cytometry, digital PCR, cryo-EM, and multi-omics approaches (transcriptomics, proteomics, lipidomics, and metabolomics). We take a multidisciplinary approach and collaborate closely with experts in bioengineering, regenerative medicine, and gene therapy to accelerate translational outcomes and therapeutic innovation in retinal disease research.
LeeRetinaLab investigates the pathobiology of age-related macular degeneration and diabetic retinopathy, with a focus on developing extracellular vesicle (EV)-based therapeutics. Our team has expertise in small EV (sEV) isolation, characterization, and bioengineering, and we regularly work with relevant animal models. To optimize sEV-based intraocular therapies, we apply both conventional and advanced technologies, including single-particle analysis, nano-flow cytometry, digital PCR, cryo-EM, and multi-omics approaches (transcriptomics, proteomics, lipidomics, and metabolomics). We take a multidisciplinary approach and collaborate closely with experts in bioengineering, regenerative medicine, and gene therapy to accelerate translational outcomes and therapeutic innovation in retinal disease research.
